Episode duration and severity as predictors of placebo response in major depressive disorder. | ClinicLens
The purpose of this study was to examine the effects of two patient-level factors, episode duration and severity, on placebo response in antidepressant clinical trials. To do this we conducted a secondary analysis of seven 8-week, randomized, double-blind, placebo-controlled tria
Medical Literature · Updated
← Back to articlesIf the embedded page does not load in your browser, open it directly.